Answer 13: Outcome measures for AECB clinical trials

20 June, 2018

 

 

The main endpoint of such studies is the time until the return to the clinical situation before exacerbation. Additional endpoints are the purulence of sputum, the volume of sputum, the daily peak-flow measurements, the quality of life, and the time until the next exacerbation.